tiprankstipranks
QuantumPharm, Inc. (HK:2228)
:2228
Hong Kong Market
2228
QuantumPharm, Inc.
RESEARCH TOOLSreports

QuantumPharm, Inc. (2228) Ratios

13 Followers

QuantumPharm, Inc. Ratios

HK:2228's free cash flow for Q4 2025 was ¥0.43. For the 2025 fiscal year, HK:2228's free cash flow was decreased by ¥ and operating cash flow was ¥-1.66. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 14.77 14.77 11.85 9.90 18.20
Quick Ratio
 14.52 14.52 11.85 9.86 18.20
Cash Ratio
 5.13 5.13 4.17 2.39 2.91
Solvency Ratio
 0.28 0.30 -3.95 -0.16 -0.14
Operating Cash Flow Ratio
 -0.29 -0.28 -1.71 -1.91 -2.17
Short-Term Operating Cash Flow Coverage
 -0.75 -0.71 -9.22 -9.46 -11.92
Net Current Asset Value
¥ 6.68B¥ 6.68B¥ 2.95B¥ -8.30B¥ -6.03B
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.03 2.76 2.19
Debt-to-Equity Ratio
 0.05 0.05 0.04 -1.52 -1.77
Debt-to-Capital Ratio
 0.05 0.05 0.04 2.93 2.29
Long-Term Debt-to-Capital Ratio
 0.02 0.02 0.00 3.07 2.33
Financial Leverage Ratio
 1.09 1.09 1.10 -0.55 -0.81
Debt Service Coverage Ratio
 -1.98 -1.86 -10.76 -25.51 -10.93
Interest Coverage Ratio
 -77.12 -54.40 -101.26 -75.44 -91.42
Debt to Market Cap
 0.01 0.01 <0.01 0.85 5.18
Interest Debt Per Share
 0.10 0.12 0.08 4.57 2.78
Net Debt to EBITDA
 5.35 5.60 1.61 -5.82 -22.74
Profitability Margins
Gross Profit Margin
69.83%69.67%46.33%27.66%49.56%
EBIT Margin
-62.96%-63.50%-268.27%-1087.46%-1074.49%
EBITDA Margin
-50.37%-49.10%-236.98%-1017.67%-292.74%
Operating Profit Margin
-54.32%-63.50%-256.80%-414.12%-393.93%
Pretax Profit Margin
16.84%16.86%-568.57%-1092.95%-1078.80%
Net Profit Margin
15.42%15.42%-569.23%-1097.57%-1078.72%
Continuous Operations Profit Margin
16.74%16.77%-568.57%-1092.95%-1078.80%
Net Income Per EBT
91.59%91.42%100.11%100.42%99.99%
EBT Per EBIT
-31.00%-26.56%221.41%263.92%273.86%
Return on Assets (ROA)
1.20%1.18%-34.83%-47.79%-33.33%
Return on Equity (ROE)
1.50%1.28%-38.26%26.34%27.00%
Return on Capital Employed (ROCE)
-4.46%-5.11%-16.79%-19.48%-12.76%
Return on Invested Capital (ROIC)
-4.35%-4.98%-16.45%-18.87%-13.15%
Return on Tangible Assets
1.23%1.21%-34.89%-47.89%-33.38%
Earnings Yield
0.34%0.38%-14.07%-15.07%-79.70%
Efficiency Ratios
Receivables Turnover
 5.15 5.05 1.95 4.53 3.52
Payables Turnover
 3.95 3.89 8.86 9.24 4.81
Inventory Turnover
 1.89 1.86 0.00 10.43 0.00
Fixed Asset Turnover
 2.19 2.14 0.65 0.31 0.33
Asset Turnover
 0.08 0.08 0.06 0.04 0.03
Working Capital Turnover Ratio
 0.13 0.16 0.00 0.06 0.04
Cash Conversion Cycle
 171.76 174.75 145.82 76.07 27.98
Days of Sales Outstanding
 70.82 72.27 187.02 80.58 103.83
Days of Inventory Outstanding
 193.27 196.21 0.00 34.98 0.00
Days of Payables Outstanding
 92.32 93.73 41.20 39.50 75.85
Operating Cycle
 264.09 268.48 187.02 115.56 103.83
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.04 -0.25 -0.23 -0.13
Free Cash Flow Per Share
 -0.05 -0.05 -0.28 -0.29 -0.18
CapEx Per Share
 0.01 0.02 0.03 0.05 0.06
Free Cash Flow to Operating Cash Flow
 1.42 1.43 1.12 1.23 1.46
Dividend Paid and CapEx Coverage Ratio
 -2.39 -2.31 -8.24 -4.34 -2.16
Capital Expenditure Coverage Ratio
 -2.39 -2.31 -8.24 -4.34 -2.16
Operating Cash Flow Coverage Ratio
 -0.33 -0.31 -3.22 -0.05 -0.05
Operating Cash Flow to Sales Ratio
 -0.19 -0.18 -1.80 -3.25 -3.22
Free Cash Flow Yield
-0.58%-0.62%-4.98%-5.50%-34.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 295.12 266.61 -7.11 -6.64 -1.25
Price-to-Sales (P/S) Ratio
 45.44 41.11 40.47 72.83 13.53
Price-to-Book (P/B) Ratio
 3.87 3.42 2.72 -1.75 -0.34
Price-to-Free Cash Flow (P/FCF) Ratio
 -172.19 -160.72 -20.09 -18.19 -2.87
Price-to-Operating Cash Flow Ratio
 -244.52 -230.19 -22.52 -22.38 -4.21
Price-to-Earnings Growth (PEG) Ratio
 1.99 -2.56 0.00 -0.20 0.04
Price-to-Fair Value
 3.87 3.42 2.72 -1.75 -0.34
Enterprise Value Multiple
 -84.87 -78.12 -15.47 -12.97 -27.36
Enterprise Value
 34.11B 29.99B 9.76B 23.03B 10.68B
EV to EBITDA
 -84.88 -78.12 -15.47 -12.97 -27.36
EV to Sales
 42.75 38.36 36.65 132.03 80.10
EV to Free Cash Flow
 -162.00 -149.98 -18.19 -32.98 -17.01
EV to Operating Cash Flow
 -229.66 -214.80 -20.40 -40.57 -24.89
Tangible Book Value Per Share
 2.19 2.49 2.08 -3.00 -1.56
Shareholders’ Equity Per Share
 2.18 2.48 2.06 -3.01 -1.56
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 0.00 0.00 -0.05
Revenue Per Share
 0.19 0.21 0.14 0.07 0.04
Net Income Per Share
 0.03 0.03 -0.79 -0.79 -0.42
Tax Burden
 0.92 0.91 1.00 1.00 1.00
Interest Burden
 -0.27 -0.27 2.12 1.01 1.00
Research & Development to Revenue
 0.71 0.71 1.57 2.76 2.69
SG&A to Revenue
 0.61 0.61 2.07 0.31 0.42
Stock-Based Compensation to Revenue
 0.08 0.00 0.51 0.51 0.33
Income Quality
 -1.21 -1.16 0.32 0.30 0.30
Currency in CNY